Vertos Medical’s $23 Million Series E Highlights Minimally Invasive Trend In Spine Surgery
Executive Summary
A $23 million Series E financing round that closed in June will allow Vertos Medical Inc. to further expand commercialization of its minimally invasive mild procedure for patients with lumbar spinal stenosis.
You may also be interested in...
CMS Opens National Coverage Analysis For Percutaneous Image-Guided Lumbar Decompression
The Medicare agency is requesting public comment on the clinical evidence of short-term and long-term health benefit outcomes of this procedure to diagnose and treat lumbar spinal stenosis.
Korean Bioclusters Offer Tax, Other Incentives To Attract Global Firms, Talent
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
CDC Panel Backs Pfizer’s Maternal RSV Vaccine But Leaves Room For AstraZeneca/Sanofi’s Beyfortus
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.